Brief: Acumen Pharmaceuticals Extends Collaboration With Lonza To Add Drug Product Manufacturing Of Sabirnetug For Early Alzheimer’S Disease
26/09/2024 13:17
Sept 26 (Reuters) - Acumen Pharmaceuticals Inc ABOS.O :
* ACUMEN PHARMACEUTICALS EXTENDS COLLABORATION WITH LONZA TO
ADD
DRUG PRODUCT MANUFACTURING OF SABIRNETUG FOR EARLY ALZHEIMER’S
DISEASE
* ACUMEN PHARMACEUTICALS INC - LONZA TO PROVIDE DP
MANUFACTURING
SERVICES FROM VISP SITE
Source text for Eikon: ID:nGNX9mDKtx
Further company coverage: ABOS.O
((Reuters.Briefs@thomsonreuters.com;))